z-logo
open-access-imgOpen Access
Everolimus versus mycophenolate mofetil in liver transplantation: every improvement in renal function matters
Author(s) -
Paolo De Simone,
Jessica Bronzoni,
Caterina Martinelli
Publication year - 2022
Publication title -
revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.8902/2022
Subject(s) - medicine , everolimus , mycophenolate , tacrolimus , liver transplantation , urology , transplantation , renal function
The current edition of the journal features a Spanish, nationwide, multi-institutional study by Gomez Bravo MA et al. exploring the advantages of everolimus (EVR)-facilitated tacrolimus (TAC) minimization versus TAC in combination with mycophenolate mofetil (MMF) after liver transplantation (LT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom